Actively Recruiting

Phase Not Applicable
Age: 0 - 30Minutes
All Genders
ID06557551

Prophylactic Surfactant by Thin Endotracheal Catheter for Preterm Infants At Birth: the ProTeCt Trial

Led by University College Dublin · Updated on 2024-10-15

164

Participants Needed

1

Research Sites

12 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are studying whether giving surfactant through a thin endotracheal catheter to extremely premature babies right after birth can reduce the need for mechanical ventilation in the first three days of life. The trial focuses on infants born before 28 weeks of gestation who are at risk of respiratory distress syndrome and usually receive breathing support with continuous positive airway pressure (CPAP). The study compares this new less-invasive surfactant method under video laryngoscopy guidance to standard face mask breathing support without surfactant. In the intervention group, at or after 5 minutes of life, a thin catheter is inserted into the baby's windpipe using video laryngoscopy to deliver surfactant, then immediately removed so the baby continues with face mask breathing support. The control group continues with face mask breathing support only. The surfactant doses vary by gestational age, and video laryngoscopy helps ensure correct catheter placement. This trial aims to see if early surfactant given this way reduces the need for ventilation and related complications. Participants are closely monitored for whether they require intubation and mechanical ventilation within the first 72 hours of life. Additional measures include the success of catheter insertion, heart rate changes, respiratory support needed, and various health outcomes up to four months or hospital discharge. The study tracks complications like bronchopulmonary dysplasia, brain hemorrhages, and other serious conditions. Overall, the trial evaluates whether this new surfactant delivery method improves breathing support outcomes in extremely premature infants.

CONDITIONS

Brief Title

Prophylactic Surfactant by Thin Endotracheal Catheter for Preterm Infants At Birth: the ProTeCt Trial

Who Can Participate

Age: 0 - 30Minutes
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Infants of any sex born before 28 weeks of gestation
  • Clinicians plan to provide intensive care
  • Consent for participation is provided by parent(s)/guardian(s) before birth
Not Eligible

You will not qualify if you...

  • Major congenital anomalies such as upper airway anomaly, diaphragmatic hernia, gastroschisis, exomphalos major, intestinal atresias, open neural tube defect, aneuploidy, or significant cardiac lesions other than ASD, PFO, VSD, or PDA

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - Shortly after birth

Participants receive surfactant through a thin endotracheal catheter inserted under video laryngoscopy shortly after birth, or continue with face mask breathing support according to their assigned group.

1 procedure at or after 5 minutes of life

Follow-up

Duration - Up to 4 months or until hospital discharge, whichever occurs first

Participants are monitored during their hospital stay for respiratory support, complications, and other health outcomes until discharge or up to 4 months of age.

Ongoing assessments during hospitalisation

Trial Site Locations

Total: 1 location

1

National Maternity Hospital

Dublin, None Selected, Ireland, D02 YH21

Actively Recruiting

Loading map...

Research Team

C

Colm PF O'Donnell, MB PhD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

Does the Use of Higher Versus Lower Oxygen Concentration Imp...

Premature Infant

Actively Recruiting

21 locations

Advanced Wireless Sensors for Neonatal Care in the Delivery ...

Sudden Unexplained Infant Death

Actively Recruiting

5 locations

The ELEVATE Program for Prediction, Early Detection & Interv...

Cerebral Palsy

Actively Recruiting

4 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Surfactant therapy via thin catheter in preterm infants with or at risk of respiratory distress syndrome.

Mohamed E Abdel-Latif, Peter G Davis, Kevin I Wheeler...

https://pubmed.ncbi.nlm.nih.gov/33970483